Insight Molecular Diagnostics Inc (IMDX)

$2.83 +0.05 (1.80%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	79.50M
Revenue (ttm)	1.88M
Net Income (ttm)	-60.66M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,226.60%
Debt to Equity Ratio	0.00

Volume	19,900
Avg Vol	85,916
Day's Range	N/A - N/A
Shares Out	28.60M
Stochastic %K	34%
Beta	0.95
Analysts	Sell
Price Target	$5.42

Company Profile

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The compa...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 949 409 7600

Website: imdxinc.com

Address:

2 International Plaza Dr., Suite 510, Nashville, United States